Global HealthQ3 FY24

Global Health Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,444.2P/E: 60.0Market Cap: ₹38.8K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2
  • Strong volume-driven growth continues across both developing (Lucknow, Patna) and mature hospitals, with 13-17% growth in inpatient footfalls and occupied bed days reported recently.
  • Developing hospitals’ revenue share has increased significantly, evidencing strong expansion momentum.
  • Noida hospital opening by end of FY25 expected to add substantial capacity and revenue streams.
  • Bed expansions planned: 140-150 beds in Lucknow and 30-40 beds in Patna by March 2024; 60 beds in Gurgaon repurposed for daycare oncology and 50 beds added to mother-child unit.
  • Focus remains on balanced tariff increases, with growth primarily driven by volumes rather than aggressive tariff hikes.
  • Continued addition of doctors (253 in nine months) to support volume growth and service expansion.
  • Opportunities being explored in UP beyond Lucknow, including Noida and potentially Eastern and Western UP, indicating longer-term growth prospects.
  • OPD pharmacy business also registering strong revenue growth of 28% year-on-year.

See what Global Health management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • The document does not explicitly mention any current or planned fundraising through debt or equity.
  • The company has a well-capitalized balance sheet to fund future expansion and growth plans.
  • Capex of approximately INR 1,770 million was incurred during the nine months ended December 2023, primarily towards the Noida hospital project.
  • The company focuses on organic growth but remains open to growth opportunities beyond organic expansions, provided they meet their strategic criteria.
  • No specific details on issuing new debt or equity were disclosed in the provided transcript.

See what Global Health management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Incurred capex of approx. INR 1,770 million for nine months ended December 2023; 66% (INR 1,170 million) toward Noida hospital project.
  • Noida hospital construction is on track with 82% superstructure completed; mechanical, electrical, and plumbing work underway.
  • Noida hospital expected to commence operations by end of FY25.
  • Plan to add 140-150 beds in Lucknow and 30-40 beds in Patna by end of March 2024.
  • Conversion of a floor in Medanta Gurugram from approx. 60 beds to daycare for medical oncology chemotherapy procedures.
  • Adding approx. 50 beds to mother and child unit in Gurugram.
  • Incorporated a SPV company (GHL Hospitals Limited) with DLF Limited to construct and operate a super-specialty Medanta Hospital in South Delhi.
  • Actively evaluating opportunities beyond current hospitals for expansion, subject to detailed due diligence and compliance.

Track Global Health — get its next earnings analysis in your feed

How does Global Health rank vs peers in Healthcare Services?

Pro feature
ThisGlobal Health
Rev 2Mar 3

How does Global Health rank in Healthcare Services?

Compare Global Health against every Healthcare Services company (Q3 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →